Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALF
Recent news which mentions ESALF
< Previous
1
2
Next >
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
August 22, 2024
Tickers
BIIB
ESAIY
ESALF
NEWS
Tags
General
Briefs
Biotech
From
Benzinga
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
July 26, 2024
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Market News
BIIB
why it's moving
From
Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Tickers
BIIB
BMY
ESALF
JNJ
Tags
General
Sanders
healthcare
From
Benzinga
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
July 03, 2024
Tickers
BIIB
ESAIY
ESALF
LLY
Tags
Benzinga
Stories That Matter
Movers
From
Benzinga
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
June 11, 2024
Tickers
BIIB
ESALF
LLY
NEWS
Tags
Media
General
Movers
From
Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
March 22, 2024
Tickers
BIIB
ESALF
ESALY
NEWS
Tags
General
Briefs
Stories That Matter
From
Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
December 08, 2023
Tickers
ESALF
ESALY
MRK
Tags
General
MRK
Market News
From
Benzinga
Biogen quarterly results top estimates despite complex launch of new Alzheimer’s treatment
November 08, 2023
Tickers
BIIB
ESALF
SPX
Tags
BIIB
ESALF
SPX
From
MarketWatch
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
November 06, 2023
Tickers
BIIB
ESALF
JNJ
LLY
Tags
PFE
NVO
JNJ
From
MarketWatch
Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge
November 02, 2023
Tickers
BIIB
ESALF
LLY
SPX
Tags
BIIB
ESALF
SPX
From
MarketWatch
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
October 25, 2023
Tickers
BIIB
ESALF
LLY
Tags
LLY
ESALF
BIIB
From
MarketWatch
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
October 13, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
General
Briefs
Government
From
Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
October 10, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Biotech
ESALY
Benzinga
From
Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
September 25, 2023
Tickers
AA
AAPL
AMZN
BIIB
Tags
ESALY
MA
AA
From
Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
September 25, 2023
Tickers
BIIB
ESALF
ESALY
Tags
General
BIIB
Market News
From
Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
September 22, 2023
Tickers
ESALF
ESALY
MRK
Tags
Biotech
ESALF
Benzinga
From
Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
August 25, 2023
Tickers
ESALF
ESALY
MRK
Tags
Health Care
ESALY
Benzinga
From
Benzinga
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
July 31, 2023
Tickers
BIIB
DGX
ESALF
LLY
Tags
ESALF
SPX
LLY
From
MarketWatch
Biogen to slash 1,000 jobs as it looks to save $700 million
July 25, 2023
Tickers
BIIB
ESALF
LLY
SAGE
Tags
LLY
SPX
ESALF
From
MarketWatch
At-home Alzheimer’s testing is on the horizon, researchers say
July 19, 2023
Tickers
BIIB
ESALF
LLY
Tags
LLY
ESALF
BIIB
From
MarketWatch
Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain
July 17, 2023
Tickers
BIIB
ESALF
LLY
SPX
Tags
LLY
SPX
ESALF
From
MarketWatch
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
July 07, 2023
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Analyst Ratings
Analyst Color
From
Benzinga
Biogen’s big Alzheimer’s drug win fails to boost the stock as analysts see slow Leqembi rollout
July 07, 2023
Tickers
BIIB
ESALF
LLY
Tags
BIIB
ESALF
LLY
From
MarketWatch
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
July 06, 2023
Tickers
BIIB
ESALF
LLY
Tags
LLY
ESALF
BIIB
From
MarketWatch
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
June 13, 2023
Tickers
BIIB
ESALF
ESALY
Tags
General
Benzinga
ESALY
From
Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
Tickers
BIIB
ESALF
ESALY
Tags
News
Large Cap
ESALF
From
Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
June 12, 2023
Tickers
AAPL
AMC
AMD
AMZN
Tags
MULN
AMZN
GME
From
MarketWatch
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
June 12, 2023
Tickers
BIIB
CCF
CVNA
ESALF
Tags
CVNA
ILMN
ESALF
From
MarketWatch
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
June 09, 2023
Tickers
BIIB
ESALF
Tags
BIIB
ESALF
From
MarketWatch
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
BIIB
ESALF
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.